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Available online 05 November 2016Based on the knownantioxidant effect offlavonoids, baicalin (baic) found in roots of Scutellariahas been selected.
Its coordination complex with the oxidovanadium(IV) cation, Na4[VO(baic)2].6H2O (V
IVO(baic)), was synthe-
sized at pH 9 in ethanol and characterized by physicochemical methods. Spectrophotometric studies at pH 9
showed a ligand: metal stoichiometry of 2:1. By vibrational spectroscopy a coordination mode through the cis
5-OH and 6-OH deprotonated groups is inferred. EPR spectroscopy shows an environment of four aryloxide
(ArO−) groups in the equatorial plane of the V_Omoiety, both in solution and in the solid complex. The antiox-
idant capacity against superoxide and peroxyl radicals of VIVO(baic) resulted greater than for baicalin and corre-
lated with previous results obtained for other VOflavonoid complexes. The coordination mode produces
delocalization of the electron density and the stabilization of the radical formed by interaction with external rad-
icals. The complex and the ligand displayed no toxic (Artemia salina test) and no mutagenic (Ames test) effects.
The complex improved the ability of the ligand to reduce cell viability of human lung cancer cell lines (A549) gen-
erating reactive oxygen species (ROS) in cells, being this effect reversed by pre-incubation of the cells with anti-
oxidants such as vitamins C and E. The addition of NAC (N-acetyl-L-cysteine, a sequestering agent of free radicals)
suppresses the anticancer effect, confirming the oxidative stressmechanism. The complex interactedwith bovine
serum albumin (BSA) with stronger binding than baicalin and the mechanisms involved H bonding and van der
Waals interactions.
© 2016 Elsevier Inc. All rights reserved.Keywords:
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Baicalin (baic, (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenyl-
chromen-7-yl)oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic
acid) is one of the major bioactive constituents of Scutellariae Radix,
widely used in traditional Chinese formulations (Fig. 1). It possesses
antiallergic, anti-inflammatory and antioxidant activity [1]. This flavo-
noid is the glucuronide of baicalein andwhile this latter compound pre-
sents good biological availability, it could not be used for its instability.
Baicalin will be the perspective lead compound for its good stability
and bioactivity.
It has been reported that the combination of antioxidant compounds
such as sulfhydryl containing organic ligands with vanadium improved
the antioxidant effect of the ligand and resulted in a new generation of
anticancer drugs [2]. Besides, in previous works we have determinedWilliams).that the complexation of the natural antioxidant compounds, flavo-
noids, by oxidovanadium(IV) produced an improvement of their anti-
oxidant properties when the interaction occurred through O atoms of
the rings that allowed a delocalization of the electronic density [3 and
references therein]. In the present case the coordination of
oxidovanadium(IV) cation (VO) through the C-5 and C-6 atoms of
baicalin, VIVO(baic), (determined by elemental analysis, thermogravi-
metric determinations, FTIR and EPR spectroscopies) produced less im-
provement in the antioxidant properties of the flavonoid than the
VOflavonoid complexes in which the coordination occurs through the
chelation with C_O (C-5) and a deprotonated hydroxo groups (at C-3
or C-5 atoms of the differentflavonoids [4]). The complex displayed bet-
ter scavenger properties against peroxyl and superoxide radicals than
the flavonoid. It also enhanced the anticancer effect of the ligand, on
A549 lung cancer cell line, being this action effect more effective at
72 h of incubation. A stress oxidative mechanism has been determined
to be at least one of the reasons of the cell viability inhibition. Baicalin
and VIVO(baic) can be stored and removed by bovine serum albumin
(BSA). The complex interacted with BSA more strongly than the ligand
and the interactions were determined to be through hydrogen bonding
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Fig. 1. Schematic representation of Baicalin.
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lina [5] it could be shown that only the oxidovanadium(IV) cation pro-
duced dead nauplii at the concentrations used for the anticancer
determinations but baicalin and VIVO(baic) did not exert toxic effects.
Besides, the compounds did not produce genetic damage that leads to
gene mutations, determined by the Ames test.2. Experimental
2.1. Materials and methods
Baicalin (Xi'an App-ChemBio(Tech) Co., Ltd) and oxidovanadium(IV)
chloride (50% aqueous solution, Carlo Erba) were used as supplied.
Corning or Falcon provided tissue culture materials. Dulbecco's modified
Eagle's medium (DMEM)was purchased from Gibco (Gaithersburg, MD,
USA), Tryple™ from Invitrogen (Argentina SRL) and fetal bovine serum
(FBS) from Internegocios, Argentina. All other chemicals usedwere of an-
alytical grade.
Elemental analysis for carbon and hydrogen was performed using a
Carlo Erba EA1108 analyzer. Vanadium content was determined by the
tungstophosphovanadic method [6]. Sodium contents were performed
by flame photometry. A Shimadzu system (model TG-50), working in
an oxygen flow of 50 mL·min−1 and at a heating rate of 10 °C·min−1
has been used for the thermogravimetric analysis. Sample quantities
ranged between 10 and 20mg. UV–vis spectra determinations were re-
corded with a Hewlett-Packard 8453 diode-array spectrophotometer.
The diffuse reflectance spectrum was performed using a Shimadzu
UV-300 spectrophotometer, with MgO as a standard. Infrared spectra
were measured with a Bruker IFS 66 FTIR spectrophotometer from
4000 to 400 cm−1 using the KBr pellet technique. X-band CW-EPR spec-
tra of powdered samples were obtained at room temperature on a
Bruker EMX-Plus spectrometer, equipped with a rectangular cavity
with 100 kHz field modulation. X band EPR spectra of frozen DMSO so-
lutions were recorded at 120 K. EPR spectra were simulated with the
EasySpin toolbox based on MATLAB [7].
Fluorescence spectra were obtained using a Perkin Elmer
(Beaconsfield, UK) LS-50B luminescence spectrometer equipped with
a pulsed xenon lamp (half peak height b10 μs, 60 Hz), an R928
photomultiplier tube, and a computer working with FLWinlab.2.2. Synthesis of Na4[VO(baicalin)2].6H2O, V
IVO(baic)
VOCl2 (50% aqueous solution, 0.125 mmol) was added to a hot
ethanolic solution (30 mL) of baicalin (0.25 mmol).The solution was
warmed (60 °C) and stirred for 1 h, and the pHwas adjusted to 9 by ad-
dition of a NaOH solution. The suspension was filtered and the green
powder, characterized as Na4[VO(baicalin)2]·6H2O (VIVO(baic)), was
washed three times with absolute ethanol and dried in an oven at
60 °C. Anal. calcd. For C42H42O29VNa4: C43.7, H3.6, V 4.4, Na 8.0.
Found: C43.6, H3.5, V 4.5, Na 8.2%. Thermogravimetric analysis (oxygen
atmosphere, velocity, 50 mL/min): In a first step (30–110 °C) the six
water molecules are lost (9.5% exp, 9.4% calcd.). Diffuse reflectance:
440 nm, 660 nm (sh), 813 nm.2.3. Spectrophotometric titrations and stability studies
To establish the stoichiometry of the complex in solution the molar
ratio method was applied. A solution of baicalin (MeOH, 4 × 10−5 M)
was prepared and its electronic spectrum recorded. The absorption
spectra of different methanolic solutions of 4 × 10−5 M baicalin and
VOCl2 in ligand-to-metal molar ratios from 10 to 0.5 (pH 9.0, main-
tained by the addition of NaOH and N2 atmosphere) were measured.
Plots of the absorbance of each solution at 316 nm vs the ligand-to-
metal ratios allowed the stoichiometric determinations. Stability studies
have been performed measuring the variation of the VIVO(baic) elec-
tronic absorption spectra with time. The dissolution of the complex
was performed in DMSO, under nitrogen atmosphere.
2.4. Antioxidant properties
The superoxide dismutase (SOD) activity was examined indirectly
using the nitroblue tetrazolium (NBT) assay. The indirect determination
of the activity of baicalin and the VIVO(baic)was assayed by their ability
to inhibit the reduction of NBT by the superoxide anion generated by
the phenazine methosulfate (PMS) and reduced nicotinamide adenine
dinucleotide (NADH) system. As the reaction proceeded, the formazan
color developed and a change from yellow to blue was observed
which was associated with an increase of the intensity of the band at
560 nm in the absorption spectrum. The system contained 0.5 mL of
sample, 0.5 mL of 1.40 mM NADH and 0.5 mL of 300 μM NBT, in 0.1 M
KH2PO4-NaOH buffer (pH 7.5). After incubation at 25 °C for 15 min,
the reaction was started by adding 0.5 mL of 120 μMPMS. Then, the re-
action mixture was incubated for 5 min. Each experiment was per-
formed in triplicate and at least three independent experiments were
performed in each case. The amount of baicalin or VIVO(baic) that
gave a 50% inhibition (IC50) was obtained by plotting the percentage
of inhibition versus the negative log of the concentration of the tested
solution.
The capacity of the compounds to scavenge hydroxyl radicals (gen-
erated by the ascorbate-iron-H2O2 system) has been measured. Briefly,
the reaction mixture contained 3.75 mM 2-deoxyribose, 2.0 mM H2O2,
100 μM FeCl3, and 100 μMEDTAwithout or with the tested compounds
in 20mMKH2PO4-KOHbuffer, pH 7.4. The reactionwas triggered by the
addition of 100 μMascorbate and themixturewas incubated at 37 °C for
30 min. Solutions of FeCl3, ascorbate, and H2O2 were made up in
deaerated water immediately before use. The extent of deoxyribose
degradation by hydroxyl radical was measured with the thiobarbituric
acid method [8].
The inhibition of peroxyl radical was measured by generation of the
radicals by the thermal decomposition of 2,2-azobis (2-amidinopropane)
dihydrochloride (AAPH) [9]. AAPHwas chosen due to its ability to gener-
ate free radicals at a steady rate for extended periods of time (half-life of
175 h). The consumption of pyranine was followed spectrophotometri-
cally by the decrease in absorbance at 454 nm with a thermostated cell
at 37 °C. The reaction solutions contained AAPH (50 mM), pyranine
(50 μM) and several concentrations of the tested compounds. The delay
of pyranine consumption (lag phase) was calculated as the time before
the consumption of pyranine started (notable reductions in absorbance
[10].
The antiradical activity of baicalin and VIVO(baic) was also measured
in terms of the capacity of the compounds to scavenge DPPH• (1,1-
diphenyl-2-picrylhydrazyl) radicals. Themeasurementswere performed
in triplicate using a modified method of Yamaguchi et al. [11]. A metha-
nolic solution of (DPPH•) (4 mL, 40 ppm) was added to 1 mL of the anti-
oxidant solutions in 0.1 M tris(hydroxymethyl)aminomethane-HCl
buffer (pH 7.1) at 25 °C, giving a final concentration of 10 μM. After
60 min in the dark, the absorbance at 517 nm was measured and com-
paredwith the absorbance of the control prepared in a similarwaywith-
out the addition of the antioxidants (this value was assigned arbitrarily
as 100%).
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2.5.1. Cell culture
Human lung cancer cell line A549 was obtained from ABAC (Ar-
gentinean Cell Bank Association INEVH, Pergamino, Buenos Aires,
Argentina). Cells were maintained at 37 °C in a 5% carbon dioxide at-
mosphere using DMEM supplemented with 100 U/mL penicillin,
100 μg mL−1 streptomycin and 10% (v/v) fetal bovine serum as the
culture medium. When 70–80% confluence was reached, cells were
subcultured using TrypLE™ from Gibco (Gaithersburg, MD, USA),
free phosphate buffered saline (PBS) (11 mM KH2PO4, 26 mM
Na2HPO4, 115 mM NaCl, pH 7.4). For the experiments, cells were
grown in multi-well plates. When cells reached 70% confluence,
the monolayers were washed twice with DMEM and then incubated
with the different compounds.2.5.2. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bro-
mide) assay
A549 cells were seeded at a density of 1 × 105/well in 48 well plates,
grown overnight and treated with either vehicle, baicalin, VIVO(baic) or
oxidovanadium(IV) at different concentrations in FBS free medium. Di-
methyl sulfoxide has been used as the dissolution vehicle to yield a
maximum final concentration of 0.5% in the treated well (Sigma-Al-
drich, St. Louis, MO). After 24, 48 or 72 h of incubation at 37 °C,
100 μg/well MTT (Sigma-Aldrich, St. Louis, MO)was added and incubat-
ed for 2 h. The formazan products generated by cellular reduction of
MTT were dissolved in DMSO and the optical density was measured at
450 nm. All experiments were performed in triplicate. Data were pre-
sented as percentage of cell viability (%) of the treated group with re-
spect to the untreated cells (control) in which the viability is assumed
to be 100%. To evaluate the cell viability in the presence of different an-
tioxidants, the cells were incubated with different concentrations of the
baicalin and VIVO(baic) plus amixture of vitamins C and E (50 μMeach)
or NAC ((N-acetylcysteine, 5mM) during 24 h. Then, theMTT assaywas
performed.2.5.3. ROS measurements
Intracellular reactive oxygen species (ROS) generation in the A549
cell line was measured by oxidation of 2′,7′-dichlorodihydrofluorescein
diacetate (H2DCFDA) to 2′,7′-dichlorofluorescein (DCF). Briefly, 24-
well plateswere seededwith 5×104 cells perwell and allowed to adhere
overnight. Then, different concentrations of baicalin, oxidovanadium(IV)
cation and VIVO(baic) were added for 24 h. Following the compounds
treatment, media was removed and cells were loaded with 10 μM
H2DCFDAdiluted in clearmedia for 30min at 37 °C.Mediawere separat-
ed and the cell monolayers rinsed with PBS and lysated into 1 mL 0.1%
Triton-X100. The cell extracts were then analyzed for the oxidized
product DCF by fluorescence spectroscopy (excitation wavelength,
485 nm; emission wavelength, 535 nm), using a Perkin-Elmer LS
50B spectrofluorometer [12]. ROS generation in cells was measured
in the presence of NAC, using the same assay as described above.
Cells were pretreated with 5 mM of NAC for 30 min, followed by
treatment with baicalin and VIVO(baic) at different concentrations
for additional 24 h.2.5.4. Cell morphology
To evaluate themorphology of the cells, theywere grown in sixwell/
plates and incubated overnight with fresh serum-free DMEM plus 0
(basal), 10 and 100 μM solutions of the complex. The monolayers
were subsequently washed twice with PBS, fixed with methanol and
stained with 1:10 dilution of Giemsa for 10 min. Next, they were
washed with water and the morphological changes were examined by
light microscopy.2.6. Toxicological assays
2.6.1. Artemia salina test
For the determination of the acute toxicity of the metal, the ligand
baicalin, VOCl2 and theVIVO(baic) complex in brine shrimp, eggs of A. sa-
linawere incubated in a hatching chamberwith artificial seawater at 20–
30 °C (One liter of seawater contains: NaCl, 23 g; MgCl2·6H2O, 11 g;
Na2SO4, 4 g; CaCl2·2H2O, 1.3 g; KCl, 0.7 g) [13]. The pH was adjusted to
9.0 using Na2CO3 to avoid risk of death to the Artemia larvae by the de-
crease of pH during incubation [5]. After 24 h, the larvae (nauplii) were
extracted and counted using a micropipette. For the oxidovanadium(IV)
cation, the ligand baicalin and the VIVO(baic) complex, six concentra-
tions (in triplicate) were tested in order to determine the dose-response
relationship and negative (distilled water) and a positive (K2Cr2O7) con-
trols were used. Concentrations tested were 300, 150, 75, 37.5, 18.75,
and 9.37 μg mL−1. The selected concentrations were in the order of
those used for the anticancer determinations. The wells containing the
sample and 10 larvae of brine shrimp, including the control groups,
were filled to a total volume of 100 μL with artificial seawater. After
24 h, live larvae were counted and the median lethal concentration
(LC50) values were estimated.
2.6.2. Ames test
The mutagenic potential of novel drugs needs to be investigated be-
cause some chemical agents which showmutagenicity can induce can-
cer [14]. Mutagenicity of the compounds was evaluated by the
Salmonella/microsome assay that is based on the plate-incorporation
method proposed by Maron and Ames [15], using Salmonella
typhimurium TA98. The test strain was obtained from frozen culture
and were grown overnight for 12–14 h at 37 °C in Mueller Hinton
broth. The different concentrations of the metal, the ligand baicalin
and the VIVO(baic) complex (300, 150, 75, 37.5 and 18.75 μg/plate)
were added to 2 mL of top agar mixed with 100 μL of bacterial culture
(1–2 × 108 cells mL−1) adding this mixture to a plate with minimal
agar. These plates were incubated at 37 °C for 48 h and the number of
His+ revertant colonies was counted. The selected concentrations
were in the order of those used for the anticancer determinations. All
experiments were made in duplicate. The Mutagenic index (MI) was
calculated as the average number of revertants per plate divided by
the average number of revertants per plate from the negative control
for each dose.
2.7. Bovine serum albumin (BSA) interaction
BSA was dissolved in Tris–HCl (0.1 M, pH 7.4) buffer to attain a final
concentration of 6 μM. Solutions of baicalin and VIVO(baic) were added
dropwise to the BSA solution and left to rest to ensure the formation of
homogeneous solutions with concentrations ranging from 2 to 100 μM
with an incubation timeof 1 h. Thefluorescence intensitywasmeasured
(excitation at 280 nm) at 298, 303 and 310 K. For each sample and con-
centration, three independent replicateswere performed. Themeasure-
ments were carried out on a Perkin-Elmer LS-50B luminescence
spectrometer (Beaconsfield, England) equipped with a pulsed xenon
lamp (half peak height b 10 ls, 60 Hz), an R928 photomultiplier tube
and a computer working with FLWinLab software. Both excitation and
emission slits were set at 10 nm throughout this study.
3. Results and discussion
3.1. Solid characterization of the complex
3.1.1. Vibrational spectroscopy
The vibrational FTIR spectral data of the solids baicalin, its sodium
salt (Na-baicalin) and VIVO(baic) in KBr pellets is displayed in Table
S1. Two components have been considered to discuss the vibrational
H (Gauss)
2600 2800 3000 3200 3400 3600 3800 4000 4200
simulated
experimental
Fig. 2. Experimental and simulated room-temperature powder electron paramagnetic
resonance spectrum of the Na4[VO(baicalin)2].6H2O complex (VIVO(baic)) measured at
X-band, 293 K, microwave frequency of 9.459 GHz.
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the flavonoid moiety.
At the pH value of the preparative (pH=9) the deprotonation of the
aliphatic hydroxylic acids has not been considered in this discussion be-
cause the ionization of these groups occurs at the remote part of the pK
scale [16]. The aromatic hydroxylic acids showed increased acidic
strength, due to the combined actions of both the electron-attracting in-
ductive effect of the aromatic ring and the mesomeric effect. Therefore,
in VIVO(baic) three acidic hydrogen atoms were removed and the first
deprotonation has been assigned to the carboxylic acid and the second
and third ionizations to the 5-OH and 6-OH groups. Despite the more
accurate designation of baicalin must be H3baic we will refer to the
deprotonated ligand herein as baic or baicalin.
The carbonyl stretchingmode of the carboxylic acid of the glucuronic
moiety has been assigned to the very strong intense band at 1728 cm−1.
Upon deprotonation of the COOH group, the carboxylate group was
formed and the two C\\O bonds became equivalent showing two
stretching bands,νas (COO−) at 1583 cm−1 (NaBaic) and1593 cm−1 (V-
IVO(baic)) and νs (COO−) at 1456 cm−1 and 1450 cm−1 for NaBaic and
VIVO(baic), respectively. The positions of these bandswere an indication
that this groupwas not involved in the coordinationwith themetal cen-
ter because the bands associated to the carboxylate anion of the sodium
salt and the oxidovanadium(IV) complex appeared at the same posi-
tions. Then, it can be concluded that the carboxylate group of the
deprotonated baicalin ligand did not bind to the oxidovanadium(IV)
cation.
The other carbonyl C_O stretching band is located at 1660 cm−1 for
baicalin has been assigned to the stretching vibration of the C4_O
group of ring B [17]. It has been reported that several metal ions coordi-
nated to baicalin through this group increased its bond order and then a
shift of the band to the red was observed in the infrared spectrum [18].
The shoulder located at 1662 cm−1 for the VIVO(baic) complex indicat-
ed that the oxidovanadium(IV) cation did not interact directly with this
group.
From Table S1 it can be seen that the major spectral shifts of the li-
gand when the interaction with the metal took place were the bands
assigned to stretching and bending modes of the C\\O and C\\OH
groups respectively. In particular the band assigned to C5\\O5
stretching shifted to the red when the H atom of the OH group is re-
placed by the V_O group, indicating an interaction of the metal ion
with this group [19].
The V_O stretching band located at relative low frequencies
(925 cm−1) was evidenced by a coordination of this cation through
cis-deprotonated oxygen atoms [3]. Then it can be concluded that the
oxidovanadium(IV) cation interacted with the flavonoid through chela-
tion with the two deprotonated OH groups located at the C5 and C6
atoms at ring A. This interaction produced a resonance of the pi system
of V_O moiety with the ring A of the ligand and therefore the V_O
bond increased in length. This conclusion is supported by the measure-
ments of the EPR spectra (see below).
3.1.2. Electron paramagnetic resonance (EPR spectroscopy)
To obtain a deeper insight into the environment of the
oxidovanadium(IV) ion, EPR spectroscopic measurements were per-
formed. The spectrum was obtained working with the microcrystalline
powder at 293 K (Fig. 2). The EPR spectrum of the VIVO(baic) gave an
eight-line hyperfine splitting pattern due to the unpaired electron of
the 51V nucleus (I= 7/2), generally being indicative of the presence of
only onemononuclear oxidovanadium(IV) species in the solid complex.
The powder experimental spectrum can be well simulated assuming g-
and A-matrices with axial symmetry. The simulation (Fig. 2) predicted
that the observed signal originated from a vanadium chromophore
was consistent with the oxidovanadium(IV) ion in a nearly axial or
pseudoaxial ligand field. The experimental parameters were gz =
g// = 1.9565; Az = A// = 154.7 × 10−4 cm−1; gx = gy = g⊥ =
1.9785; Ax=Ay=A⊥=50.8 × 10−4 cm−1. To calculate themagnitudeof Az, the additivity relationship for oxidovanadium(IV) complexes,
Az =∑niAz,i, introduced by Chasteen [20] has been used. In this equa-
tion, ni is the number of equatorial ligands of type i and Az,i is the contri-
bution to the parallel hyperfine coupling of the most probable
coordination environment. This constant can provide the identity of
the equatorial donor sets coordinated to the V(IV)O2+ cation because
each donor group made a specific contribution and the sum of the con-
tributions of the four equatorial ligands can be compared with the ob-
served experimental value. Taking into account the probable and
expected donor set, considering four ArO− groups with a contribution
to Az = ArO−, 38.6 × 10−4 cm−1, the Az value of 154.4 × 10−4 cm−1
has been calculated, in agreementwith the experimental one. A binding
mode involving an equatorial coordination sphere with two oxygen
atoms from two ArO− groups of each flavonoid moiety (from ring A)
is then suggested. This coordination agreed with the well-known spec-
tral features of bis chelated V(IV)O2+ complexes in which two 1,2-
diolate moieties are bound to oxidovanadium(IV). This 2x(O−, O−) co-
ordination mode of V(IV)O2+ was substantiated with sugars and their
derivatives provided with at least a cis couple of deprotonated hydroxy
groups [21].
Besides, it has been reported that the flavonoid baicalein (the agly-
cone of baicalin) also formed anionic V(IV)O2+ penta-coordinated com-
plexes with square pyramidal geometry and 2x(O−, O−) or “catechol-
like” coordination in solution at pH values higher than 7.4, bearing sim-
ilar EPR parameters (gII= 1.954; AII=155.3 × 10−4 cm−1). This type of
coordination has been described to occur through the C\\O− groups of
ring A in positions 6 and 7 (or 5 and 6) for baicalein. Herein, with the
glycosidic linkage located at the 7 position, we could determine that
the coordination of the ligand to the metal occurred unequivocally
through the 5 and 6 groups of ring A [22].
Considering the elemental analysis of the compound and the FTIR
and EPR data, we can conclude that the structure of the VIVO(baic) com-
plex agree with the schema depicted in Fig. 3.
3.2. Solution studies
3.2.1. Solution EPR spectrum
To determine whether the structure of the solid complex has been
retained in solution the EPR spectrum (X-band) has also beenmeasured
from the dissolution of the solid complex in DMSO (120 K, 1.25 mM).
This solvent is generally used as a solvent in EPR measurements of
V(IV) compounds because it allows for a glass-like solidification of
(and thus maintenance if isotropic conditions in) the solution at low
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Fig. 3. Schematic representation of the complex VIVO(baic).
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solid complex for the biological measurements. The EPR signal (Fig. 4)
shows the typical eight-line pattern spectrum for V(IV)O2+ systems.
The solution experimental spectrum can be well simulated assuming
g-and A-matrices with rhombic symmetry. This signal indicated the
presence of single mononuclear species after the dissolution process.
The spectral simulation (Fig. 4) predicted the formation of a VIVO chro-
mophore with spin Hamiltonian parameters gz = 1.9505, gx = 1.9824
and gy = 1.9762 and hyperfine coupling constants of Az =
155.1 × 10−4 cm−1, Ax = 39.3 × 10−4 cm−1, and Ay =
53.7 ×10−4 cm−1. The calculatedAz value is indicative of a coordination
sphere similar to that of the solid complex, showing that the coordina-
tion sphere has been retained upon dissolution of the solid compound.
3.2.2. UV–vis spectra
The UV–vis absorption spectra of an aqueous solution of baicalin at
different pH values have previously been reported [23]. Fig. S1 shows
the spectral data obtained for a DMSO/EtOH (1/100 dissolution) of
5 × 10−5 M baicalin at different pH values.
At pH values lower than 6 two bands were observed at 279 nm (re-
lated to ring A, benzoyl, π → π*) and 316 nm (related to ring B,
cinnamoyl, n→ π*). The band of higher energy decreased its intensity
from pH values 2 to 6. The band related to ring B shifted to 306 nm atH (Gauss)
2600 2800 3000 3200 3400 3600 3800 4000 4200
simulated
experimental
Fig. 4. Frozen solution EPR spectrum of 1.25 mM VIVO(baic) in DMSO recorded at 120 K,
microwave frequency of 9.452 GHz, and the simulated spectrum.pH values higher than 7. Themost important spectral changes appeared
at pHvalues higher than 7, inwhich thedeprotonation of C\\6OHgroup
takes place generating a charge transfer band at 420 nm due to the do-
nation of electrons to the ring. Because of the intramolecular hydrogen
bond between 5-OH\\O4_C groups that stabilize the 5-OH group in
its acidic form, the deprotonation of C\\5OH group occurred at pH
values higher than that of the hydroxyl group located on C6 (pKa1 =
7.6, pKa2 = 10.1) [23]. The ionization of the carboxylic group (from
the glucuronic moiety) occurred at pH values lower than 5 and did
not affect the spectral pattern of baicalin. At a 100 times higher concen-
tration of the flavonoid (5 × 10−3 M) a new band at ca. 600 nm (ε,
40 M−1 cm−1, pH 8) has been detected (Fig. S2). At higher pH values,
this band shifted to the blue denoting again that a new deprotonation
occurred in the ligand (567 nm, ε 34 M−1 cm−1, pH 9). The UV–vis
spectral changes of a DMSO/EtOH (1/100 dissolution ) of VOCl2·H2O
(2.5 × 10−5 M) and baicalin (5 × 10−5 M) at different pH values,
depicted in Fig. S3, showed a similar pattern to that of the ligand.
When the concentration of the solution is 100 times greater, the visible
part of the electronic spectrum due to the oxidovanadium(IV) cation
has been detected. Two bands at 610 nm (372 M−1 cm−1) and
795 nm (516 M−1 cm−1) were observed up to pH 5 that resembles
the spectrum of a carboxylate-oxidovanadium(IV) complex (Fig. S4)
[24]. At pH 9 a single band is observed at 610 nm (204M−1 cm−1). De-
spite the visible part of the spectrum at high energy ismasked by the in-
tense band of the UV region, this spectrum could be comparedwith that
of a coordination sphere with (O−,O−) groups linked to the V(IV)O2+
cation [25]. The band of the ligand at 600 nm is of low intensity and
did not interfere with these observations.
The spectrophotometric titration has been performed following the
spectral variation of an ethanolic 4 × 10−5 M solution of baicalin at
pH 9 with the successive addition of VOCl2 at different ratios, at
316 nm. A ligand-to-metal ratio 2–1 has been obtained in agreement
with the stoichiometry of the solid complex (see Fig. 5).
The complex remained stable in a DMSO solution (no appreciable
changes were observed in the UV–vis spectra) at least during 1 h.
Then it can be stated that the complex did not decompose during the
manipulation of the solution for the biological studies.3.3. Antioxidant determinations
The antioxidant properties have been evaluated bymeans on the ca-
pacity of the compounds to scavenge reactive oxygen species (ROS) in
vitro. In addition, the capacity of the reduction of the concentration ofλ (nm)
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Fig. 5. UV–vis spectra of baicalin (4 × 10−5 M) with the addition of VOCl2 in ligand-to-
metal ratios from 10.0 to 0.7 (pH 9), nitrogen atmosphere. Inset: spectrophotometric
determination of VIVO(baic) complex stoichiometry at 316 nmby themolar ratiomethod.
Table 1
Antioxidant activities of baicalin, VIVO(baic) and the oxidovanadium(IV) cation.
O2•−
(IC50, μM)
DPPH• %
scavenge
50 μM
OH• %
scavenge
50 μM
ROO• (lag
phase, min
at 10 μM)
Baicalin N100 95 59 4
VIVO(baic) 66 95 64 11
V(IV)O2+ 15 (SOD, 0.21) 14 18 b1
Table 2
IC50 values of baicalin and VIVO(baic) at 24, 48 and 72 h incubation.
IC50 (μM), 24 h IC50 (μM), 48 h IC50 (μM), 72 h
Baicalin N100 N100 77.4 ± 2.7
VIVO(baic) N100 44.7 ± 3.5 21.7 ± 1.3
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(Table 1).
Baicalin did not display SOD activity while the complexation im-
proved the capacity of dismutation of superoxide anion showing amod-
erate activity (IC50 = 65.8 μM) in comparison with the activities of the
oxidovanadium(IV) cation (IC50 = 15 μM) and native SOD (IC50 =
0.21 μM). The flavonoid showed amoderate activity on the peroxyl rad-
ical scavenging (phase lag of pyranine consumption of 4 min, 10 μM)
while VIVO(baic) increased the lag time and showed a better activity
than the ligand and even than that of the good antioxidant compound
Trolox. Both baicalin and VIVO(baic) showed a similar antioxidant activ-
ity against OH● radicals scavenging ca. 60% of the radicals at a 50 μM
concentration and were able to scavenge 95% of the DPPH•.radicals at
50 μM. In addition to ensure that the antioxidant effects found for
baicalin agree with previously reported values [26,27] it can be seen
that the complexation improved the antioxidant activity of the flavo-
noid in particular for the ROS superoxide and peroxyl radicals.
According to previous results [3 and references therein] when V_O
coordinated to the C4_O and C3\\O\\or C5\\O\\groups, the electrons
of the π system of V_O are able to delocalize in the rings A and C (in
the case that a double bond between C2 and C3 is present) and this
group of flavonoids has previously been labeled as group I. In this
group of VOflavonoid complexes (flavonoid = quercetin, naringenin,
chrysin, silibinin, morin) the antioxidant properties of the complex are
better than those for the parent flavonoid due to the high stability of
the radical formed by the flavonoid upon interaction with an outer
free radical. On the contrary,when the coordination involvedOHgroups
in cis- position on ring B or a distant substituent of rings B or C (hesper-
idin, luteolin, diosmin, [28] the complex formation did not improve the
antioxidant properties of the ligand. In the VIVO(baic) complex the in-
teraction occurred through the phenolate groups on ring A, and then aConcentration, μM
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Fig. 6. Inhibitory effects of baicalin (triangles), VIVO(baic) (squares) and oxidovanadium(IV)
cation (circles) on A549 cell viability. The cell line was treated with various concentrations
of the compounds for 24 h. The results are expressed as the percentage of the control level
and represent the mean ± the standard error of the mean (SEM) from three separate
experiments. * significant values in comparison with the control level (P b 0.05).π electron delocalization is feasible, and an improvement of the antiox-
idant properties of the flavonoid upon complexation is observed.
3.4. A549 cell line assays
3.4.1. Cell viability
Baicalin inhibited different cancer cell lines growth like acute lym-
phocytic leukemia (ALL) [29], prostatic cancer cell lines [30] human
(KU-1 and EJ-1), murine (MBT-2) bladder cancer cell lines [31] and
A549 human lung cancer cells [32]. The cytotoxicity of baicalin, V-
IVO(baic) and oxidovanadium(IV) cation on A549 cell line was deter-
mined by MTT assay. As shown in Fig. 6, the oxidovanadium(IV)
cation induced no cytotoxicity to human lung cancer cells at the tested
concentrations. Baicalin behaved as a slightly anticancer agent,
inhibiting 20% of cell viability at 100 μM (IC50 N 100 μM), as it was pre-
viously found [32]. The complex VIVO(baic) exhibited its cytotoxic effect
in a dose-responsemanner (the survival cells were 65% of the control at
100 μM). It can then be seen that the complexation improved the action
of the free ligand, similar to previous determinations for copper and al-
uminium baicalin complexes [33].
When the time of incubation of the cells with the different com-
pounds increased, an improvement of their anticancer effects has been
observed (Table 2). At 72 h incubation an IC50 value of 77.4 μM was
found for baicalin, in agreement with previous results [34–36] and
21.7 μM for VIVO(baic). In all cases VIVO(baic) improved the action of
the ligand displaying a time-dependent behavior with low IC50 values.
Therefore, it can be demonstrated that the exposition time affected
the cell viability and at 72 h incubation the complex showed a strong
deleterious effect on the A549 cell line.
3.4.2. Mechanism of action
Reactive oxygen species (ROS) like hydroxyl radical (OH●), superox-
ide anion radical (O2●-), hydrogen peroxide (H2O2), peroxyl radicals
(ROO●), nitric oxide (NO●) and reactive nitrogen species (RNS) areConcentration, μ M
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Fig. 7. Effect of baicalin, VIVO(baic) and oxidovanadium(IV) cation on H2DCFDA oxidation
to DCF. A549 cells were incubated at 37 °C in the presence of 10 μMH2DCFDA. The values
are expressed as the percentage of the control level and represent the mean ± SEM. *
significant values in comparison with the control level (P b 0.05).
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Fig. 8. Inhibitory effects of baicalin (triangles) andVIVO(baic) (squares) on A549 cell viability in the presence of amixture of vitamins C and E (each at 50 μM) (A) andNAC (B). The cell line
was treated with various concentrations of the compounds and a mixture of vitamins and NAC at 37 °C for 24 h. The results are expressed as the percentage of the control level and
represent the mean ± the standard error of the mean (SEM) from three separate experiments. All values are not different to the control level (P b 0.05).
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Fig. 9. Effect of N-acetyl-L-cysteine (NAC, 5 mM) on ROS production induced by baicalin
and VIVO(baic). The values are expressed as a percentage of the control level and
represent the mean ± SEM. * significant values in comparison with the control level
(P b 0.05).
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causing oxidative damage when produced in excessive quantities. ROS
have been implicated in the pathogenesis of a wide variety of human dis-
eases that alter the function of genetic apparatus and can oxidize and
damage nucleic acids, proteins and lipids, which are the major compo-
nents of cell membranes and also lead to cell death [37]. For a better un-
derstanding of the possible mechanisms involved in the cytotoxicity of
the compounds in the A549 cell line, we evaluated the effect of baicalin
and VIVO(baic) on cellular ROS generation through the oxidation of the
H2DCFDA probe. The results showed that oxidovanadium(IV) cation did
not increase the cellular ROS levels (Fig. 7) andVIVO(baic) produced an in-
crement of ROS levels in a dose-dependentmannerwith statistical differ-
ences in the whole range of concentrations (p b 0.05). At 100 μM
concentration the complex caused ca.260%of ROS increment over theun-
treated cells andbaicalin produced a low increment of ROS levels (150% at
100 μM). The increase of the reactive oxygen species with the concentra-
tion of the added compounds is consistent with the higher inhibition of
the cell viability produced by the flavonoid and the complex in a dose re-
sponse manner.
3.4.3. Effect of ROS on cell viability
Free radicals either produced from the normal cell metabolisms or
from external sources, are scavenged by the second line of defense of
the body: non-enzymatic antioxidants namely, vitamin C (ascorbic
acid), vitamin E (tocopherol), and reduced glutathione [38]. Vitamin C
scavenges superoxide, hydroxyl, hydrogen peroxide and singlet oxygen
radicals and is oxidized by a variety of other oxidants such as halogens,
quinones, and phenoxyl radicals. Vitamin E is themost important lipid-
soluble antioxidant in humans. It is a scavenger of peroxyl radicals and
therefore inhibits the chain reactions in lipid peroxidation [39]. To de-
termine the effects of ROS on the cell viability, human lung cancer
cells were incubated with baicalin and VIVO(baic) and natural antioxi-
dants (mixture of vitamins C and E). It can be observed from Fig. 8A
that baicalin and VIVO(baic), behaved like the untreated cells, being
the cell viabilities like those of the basal-like cells. The same results
were obtained using other scavenger of free radicals, N-acetyl-L-cyste-
ine (NAC) Fig. 8B. It can be seen that while the added compounds gen-
erate oxidative stress in the cell lines producing the inhibition of the
cellular viability, the incubation of the compounds with the addition
of strong antioxidants prevent cellular death by the scavenge of the gen-
erated free radicals.
To confirm this hypothesis the cellular ROS levels were measured in
the cell lines again with the pre-treatment of N-acetyl-L-cysteine (NAC)
and baicalin or VIVO(baic). It can be seen in Fig. 9 that the ROS levelswere completely reduced to the natural ROS contents of the untreated
cancer cell line. The comparison with the results shown in Fig. 7 sug-
gested that the oxidative stress generated by the action of the baicalin
and VIVO(baic) in the absence of antioxidant agents is a possible mech-
anism of cell death, in agreementwith some results reported for the fla-
vonoid baicalin [40,41].
3.4.4. Morphological changes
Taking into account the cytotoxic effects of VIVO(baic) on the human
lung cancer cells we investigated its action on the cell morphology (Fig.
10). Most untreated A549 cells showed a pebble-like shape and cell-cell
close adhesion [42]. Upon treatment with 100 μM VIVO(baic) for 24 h
morphological changes were observed. The cells showed condensation
of the cytoplasm and narrow protrusions appeared.
3.5. Toxicological assays
3.5.1. Artemia salina Tests
The brine shrimp test has been widely used to test the toxicity of a
great variety of products. Although the substitution of laboratory ani-
mals for toxicity studies by A. salina needs further investigation, it has
previously been demonstrated that toxicity assays studies on the LC50
of medicinal plant extracts using A. salina correlated well with the cor-
responding oral lethal dose (LD50) in mice [43]. The mortality of brine
shrimp for every concentration of VOCl2 is shown in Table 3. The
control 10 µM VObaic 100 µM VObaic
Fig. 10.Effect on cellmorphologyof the treatment of A549 cell linewith VIVO(baic). Cellswere incubated for 24 hwithoutdrugaddition (control) andwith VIVO(baic) (10 and100 μM,40 x).
Table 4
Induction of His + revertants (Rev) in Salmonella typhimurium TA98 by the
oxidovanadium(IV) cation, the ligand baicalin and the VIVO(baic) complex without meta-
bolic activation (S9 mix).
Concentration (μg/plate)
S. typhimurium TA98
Rev/platea MIb
Strain control 34.5 ± 0.5 –
VOCl2 75 26 ± 3 0.75
37.5 30 ± 2 0.87
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allowed us to determine LC50 value (244 μM), which is the dose re-
quired to kill half of the members of the tested population. On the
other hand, dead nauplii were not observed for the ligand baicalin and
the VIVO(baic) complex at the tested concentrations showing that the
flavonoid and the complex did not exert toxic effects.
3.5.2. Ames test
The Artemia salina L. test is useful for the screening of novel drugs in
order to predict their toxicity and has shown a good correlation (r =
0.85 p b 0.05) with the assays in mice, suggesting that the brine shrimp
bioassay is a useful alternative model [44]. The Ames Salmonella
typhimurium assay has been used to identify substances that can produce
genetic damage that leads to gene mutations. The test uses Salmonella
strains with preexisting mutations that are not capable to synthesize his-
tidine, and then are not able to growor form colonies in its absence. Com-
pounds with mutagenic potential may restore the genes function
(reversion assay). Consequently, a positive test indicates that the com-
pound is mutagenic and therefore may act as a carcinogen. A sample
was considered positive when the mutagenic index (MI) was equal or
N2 for at least one of the tested doses and if it had a reproducible dose-re-
sponse curve [15]. It can be seen in Table 4 that the oxidovanadium(IV)
cation, the ligand baicalin and the VIVO(baic) complex did not exert mu-
tagenic action on the tested strain. At the higher added concentrations
(1 and 0.5 mM) the MI value of the oxidovanadium(IV) cation could
not be detected because of the antimicrobial action exerted by VOCl2
against Salmonella typhimurium TA98. The mutagenic index value result-
ed lower than 2 in all the cases and showed that the tested substances
could not induce an increase in the number of revertants. These results in-
dicated that the oxidovanadium(IV) cation, the ligand baicalin and the V-
IVO(baic) complex did not induce frameshift mutations at the tested
concentrations.
3.6. Bovine serum albumin (BSA) interaction
3.6.1. Fluorescence quenching studies
The interaction between biomacromolecules, especially those be-
tween plasma proteins and drugs, has been an interesting researchTable 3
Mortality produced by VOCl2 and LC50 estimated
values using Artemia salina test.
LC50 value (μg mL−1) 33.71
[VOCl2] (μg mL−1) Mortality (%)
300 100
150 100
75 100
37.5 46.7
18.75 40
9.37 20field in life sciences, chemistry, and clinical medicine. Bovine serum al-
bumin (BSA) is used as the model protein for drug delivery because of
its medical importance, abundance, low cost, ease of purification, un-
usual ligand-binding properties and that it is widely accepted in the
pharmaceutical industry. The studies concerning the interaction and
potential transport with bovine serum albumin were made with
baicalin and VIVO(baic) measuring the fluorescence intensity of the
BSA before and after the addition of these compounds. The interaction
with oxidovanadium(IV) cation was previously discussed [45]. It has
been demonstrated that the increment of concentrations of V(IV)O2+
barely produced a 10% quenching at the higher tested concentration
values.
On the knowledge that the protein has two tryptophan residues (lo-
cated at positions 134 and 212, respectively) that possess intrinsic fluo-
rescence [46] the strong fluorescence emission of BSA can be observed
(Fig. 11). On the contrary, baicalin and VIVO(baic) displayed almost no
intrinsic fluorescence under the experimental conditions (data not
shown). The fluorescence intensities of BSA decreasedwith the increase
of the concentration of the added compounds, accompanied by a red
shift of themaximum emissionwavelengths in the fluorescence spectra
indicating interactions between the compounds and the protein. The
red shift of the emission band produced by the change in the environ-
ment sensed by the tryptophan in BSA suggested that tryptophan has
been brought tomore hydrophilic environment changing the secondary
structure of the protein [47]. It can be observed that VIVO(baic) led to
total quenching at 40 μM concentration and that baicalin quenched ca.
70% of the fluorescence intensity of BSA at the same concentration.18.75 30 ± 2 0.87
baicalin 300 32 ± 1 0.93
150 37.5 ± 1.5 1.09
75 34 ± 1 0.98
37.5 45 ± 1 1.30
18.75 35 ± 1 1.01
VIVO(baic) 300 33 ± 2 0.96
150 30 ± 1 0.87
75 31 ± 1 0.89
37.5 25.5 ± 0.5 0.74
18.75 24.5 ± 0.5 0.71
a Number of revertants/plate: mean of two independent experiments ± SD.
b MI:mutagenic index (number ofHis+ induced in the sample/number of spontaneous
His+ in the negative control).
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Fig. 11. The fluorescence spectra of BSA at various concentrations of baicalin (A) and VIVO(baic) (B). λex = 280 nm, [BSA] = 6 μM, T= 310 K.
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ferent temperatures with the Stern-Volmer Eq. (1) have been analyzed,
[48] using the following equation:
F0=F ¼ 1þ Kqτ0 Q½ Š ¼ 1þ KSV Q½ Š ð1Þ
where F0 and F are the fluorescence intensities in the absence and
presence of quencher, respectively; Kq is the bimolecular quenching
constant; τ0 is the lifetime of the fluorophore in the absence of quench-
er; [Q] is the concentration of quencher and Ksv is the Stern-Volmer
quenching constant which can be obtained from the slope of Eq. (1).
Fig. 12 displays the Stern-Volmer plots of the quenching of BSA fluo-
rescence by baicalin (A) and VIVO(baic) (B) at different temperatures. It
can be observed that the plots largely deviated from linearity toward
the y-axis at concentrations higher than 30 μM. The upward curvature
indicated that the quenching type is a combined quenching (both static
and dynamic) [49] but at lower concentrations a single quenching (stat-
ic or dynamic) probably takes place. The Stern-Volmer plots were used
to elucidate these assumptions at lower concentrations, and a linear
correlation has been obtained for both compounds (insets, Fig. 12C
andD, respectively). In Table 5 the calculated values of Ksv are presented
showing a decrease with temperature. When the bimolecular
quenching constants Kq are calculated using the well-known relation-
ship (Kq = Ksv/τ0, τ0 = 10−8 s, Table 5), values much greater than
the maximum dynamic quenching constant 2.0 × 1010 M−1 s−1 have
been obtained. These results suggested that the interaction betweenQ, M
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Fig. 12. Plots of F0/F vs [Q] for BSA with baicalin (A) and VIVO(baic) (B) at different temperature
VIVO(baic) (D).the compounds and BSA most probably occurred by static quenching
[50].
3.6.2. Binding constants and the number of binding sites
The determination of the level of compound binding with serum al-
bumin is critical and will directly correlate with the transport, disposi-
tion, and in vivo efficacy of the compound. The value of Ka is essential
to understand the distribution of compounds in plasma since a weak
binding can result in comparatively high concentrations of the drug in
theplasma, resulting in a shorter life timewhile a strongbinding can de-
crease the concentrations of compound in plasma, improving the phar-
macological effect.
On the assumption that the fluorescence quenching of protein could
be a static quenching process (complex formation between protein and
quencher), the equilibrium between free and bound molecule could be
given by the following Eq. (2)
log F0−Fð Þ=F½ Š ¼ logKa þ n log Q½ Š ð2Þ
where Ka and n are the binding constant and the number of binding
sites, respectively. The Ka and n per BSA at different temperature ac-
quired from the plots in Fig. 13 were listed in Table 5. It was found
that the binding constant decreased with an increase in temperature,
resulting in a reduction of the stability of the compound-BSA system.
Comparing the binding constants of baicalin-BSA and VIVO(baic)-BSA
systems, it was found that the binding with the complex was stronger
than that of the free ligand. The number of binding sites of theQ, M
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Table 5
Stern-Volmer constant (Ksv), quenching rate constant (Kq), binding constant (Ka) and n binding sites for the interaction of baicalin and VIVO(baic) with BSA (6 μM) in Tris–HCl buffer
(0.1 M, pH 7.4).
Compounds T (K)
Ksv (×104)
(M−1) r2
Kq (×1012)
(M−1 s−1)
Ka (×106)
(M−1) n
Baicalin 298 7.86 ± 0.52 0.98 7.86 ± 0.52 5.13 ± 0.31 1.39 ± 0.06
303 7.79 ± 0.78 0.98 7.79 ± 0.78 3.06 ± 0.17 1.35 ± 0.03
310 7.10 ± 0.53 0.99 7.10 ± 0.53 1.02 ± 0.23 1.25 ± 0.02
VIVO(baic) 298 41.57 ± 0.22 0.99 41.57 ± 0.22 13.48 ± 0.46 1.39 ± 0.05
303 33.27 ± 0.35 0.99 33.27 ± 0.35 6.61 ± 0.82 1.33 ± 0.07
310 20.06 ± 0.57 0.97 20.06 ± 0.57 2.51 ± 0.21 1.26 ± 0.03
r2 is the correlation coefficient for the KSV values.
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the binding sites with high affinity. These data suggested that baicalin
and VIVO(baic) can be stored and removed by BSA. Our results for n
and Ka agree with previous data reported for baicalin [51]. On the
other hand it is important to mention that there are some discrepancies
in the literature for the interaction of baicalin with albumin being the
Ksv, Ka and the thermodynamic parameters quite different from each
other. These differences could be attributed to the different experimen-
tal conditions used in each determination (differences in albumin and
flavonoid concentrations, albumin fractions and/or dissolution media)
[51–53].
3.6.3. Thermodynamic parameters
The interaction forces between drugs and biomolecules may include
electrostatic interactions, multiple hydrogen bonds, van der Waals in-
teractions, hydrophobic and steric contactswithin the antibody-binding
site, etc. [54]. To infer the type of process of the interaction between
baicalin and VIVO(baic) with BSA, thermodynamic parameters, includ-
ing enthalpy change (ΔH), entropy change (ΔS) and free energy change
(ΔG) were investigated. If ΔH does not vary significantly over the tem-
perature range studied, then its value and that of ΔS can be evaluated
from the van't Hoff Eq. (3):
lnKa¼−ΔH=RTþ ΔS=R ð3Þ
where Ka is analogous to the associative binding constants at the cor-
responding temperature and R is the gas constant. The free energy
change (ΔG) is then estimated from the following relationship (4):
ΔG ¼ ΔH–TΔS ð4Þlog [Q]
l
o
g
[
(
F
0
-
F
)
/
F
]
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
-5.8 -5.6 -5.4 -5.2 -5.0 -4.8 -4.6 -4.4 -4.2 -4.0 -3.8
Fig. 13. Plots of log [(F0− F)/F] vs. log [Q] for the baicalin-BSA system (A) and VIVO(baThe negative sign obtained forΔG (Table 6) indicated a spontaneous
interaction process. The negative enthalpy change suggested that the
binding between the compounds and BSA was exothermic and then
the association constant decrease with increasing temperature [54].
An important source of a negative contribution to ΔH and ΔS will arise
if a hydrogen bond is formed and furthermore the interactions involving
delocalized electrons of aromatic ring systems make significant contri-
butions to their negative sign. The negative ΔH and ΔS values obtained
for the interaction of baicalin and VIVO(baic)with BSA indicated that the
binding is mainly enthalpy driven with an unfavorable entropic factor
and therefore the hydrogen bonding and van der Waals forces played
major roles during the interactions [54].4. Conclusions
As part of a project devoted to design new anti-cancer compounds
with the natural antioxidant plant compounds, flavonoids and the
oxidovanadium(IV) cation, we have synthesized and characterized a
new solid complex with baicalin. In hot ethanolic solution at pH 9 a
1:2 metal-to-ligand solid complex has been obtained. Physicochemical
determinations allowed the characterization of the solid complex. At
such pH value the ligand is triple deprotonated leading to the formation
of a bis-chelate compoundwith the oxidovanadium(IV) cation inwhich
the coordination occurred through the phenoxy groups of ringA. By EPR
spectroscopy it has been demonstrated that the equatorial environment
was retained upon dissolution of the complex in DMSO. The antioxidant
properties of baicalin are of medium intensity owing to the absence of
hydroxyl groups on ring B and the 3-OH group on ring C.
Oxidovanadium(IV) complexation enhanced the radical-scavenger ac-
tivity for superoxide and peroxyl ROS. Even though and due to itslog [Q]
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ic)-BSA system (B): (●), 298 K; (▲), 303 K; (■), 310 K, [BSA] = 6 μM, λex = 280.
Table 6
Thermodynamic parameters for the interactions between baicalin and VIVO(baic) with
BSA.
Compounds ΔH (KJ/mol) ΔS (J/mol) ΔG (KJ/mol)
Baicalin −104.40 −221.14 −38.84 (298 K)
−37.74 (303 K)
−36.20 (310 K)
VIVO(baic) −104.44 −214.15 −40.62 (298 K)
−39.98 (303 K)
−38.05 (310 K)
160 J.J. Martínez Medina et al. / Journal of Inorganic Biochemistry 166 (2017) 150–161structural characteristics the antioxidant capacity of the complex is
moderate, the peroxyl scavenging power is one of the higher measured
activities among a family of VOflavonid complexes studied. Using the
brine shrimp test it can be determined that both baicalin and VIVO(baic)
did not display toxic effects and they did not exertmutagenic and there-
fore carcinogenic effects (Ames test).We found that baicalin slightly de-
creased the number of viable human lung cancer cells and that the
coordination with oxidovanadium(IV) improved its action, especially
noticeable at 72 h incubation times. A stress oxidativemechanism of ac-
tion has been determined in concordance with the observations that
when the generation of cellular ROS was suppressed the cell viability
behaved like that of the untreated cells. Because of the decrease of the
Ksv values of baicalin and VIVO(baic) with the temperature and the
high Kq values, greater than the maximum dynamic quenching con-
stant, we can conclude that that a static quenching occurs during the in-
teraction between the compounds and BSA at low concentrations. The
thermodynamic parameters indicated that both compounds could be
transported by the protein with spontaneous processes (ΔG b 0) and
the presence of H bonding and van der Waals interactions (ΔH b 0
and ΔS b 0) between the protein and the added compounds.
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